APG IV system

APG IV system is the fourth version of a modern, primarily molecular-based, system of plant taxonomy for flowering plants (angiosperms). The system was published in April 2016 by the Angiosperm Phylogeny Group, and it updates the previous version, the APG III system, which was published in 2009. The APG IV system is widely accepted by the botanical community and is used in many herbaria, botanical gardens, and research institutions around the world.
Overview[edit]
The APG IV system is a classification scheme that reflects the latest understanding of the evolutionary relationships among flowering plants. It is based on DNA sequencing and other molecular data, which have provided new insights into the phylogeny of plants. This system organizes plants into clades, which are groups consisting of a single ancestor and all its descendants. This approach differs from traditional classification systems, which were primarily based on morphological characteristics.
Major Changes from APG III[edit]
One of the significant updates in the APG IV system is the reclassification and renaming of several orders and families. For example, the system provides a more detailed classification of the early-diverging lineages of flowering plants, including the orders Amborellales, Nymphaeales, and Austrobaileyales. Additionally, it recognizes new families and orders that were not previously included in the APG III system, reflecting the ongoing discovery and analysis of plant relationships.
Classification[edit]
The APG IV system classifies flowering plants into orders and families. It does not provide a classification below the family level (such as genera and species), as these are more subject to change and often require more detailed, localized study. The system is hierarchical, with the major groups being:
- Monocots and Eudicots: These are the two largest clades of flowering plants. The APG IV system provides an updated classification for these groups, recognizing their evolutionary divergence and the relationships among their various lineages.
- Magnoliids, Chloranthales, and other early-diverging lineages of flowering plants: These groups represent some of the earliest branches in the evolutionary tree of flowering plants. The APG IV system provides a clearer understanding of their relationships and classification.
Impact[edit]
The APG IV system has had a significant impact on botanical research and education. It has led to a reevaluation of many traditional plant classifications and has provided a more accurate understanding of plant evolution. The system is used in a wide range of botanical fields, including taxonomy, phylogenetics, conservation biology, and ecology.
Future Directions[edit]
As molecular and genomic technologies continue to advance, it is expected that the APG system will be further updated. Future versions will likely incorporate more data from genomics, transcriptomics, and other areas of molecular biology, potentially leading to further refinements in the classification of flowering plants.

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian